Covid booster vaccine trial bids to recruit 185 volunteers
Nurse Eleanor Pinkerton prepares a coronavirus vaccine (Jane Barlow/PA)
A health board has started its appeal to recruit 185 volunteers for a world-first clinical trial to see whether a booster vaccine dose could protect people against Covid-19 and its variants.
NHS Greater Glasgow and Clyde (NHSGGC) is the only area in Scotland taking part in the trial, which will be run at Glasgow Clinical Research Facility.
In total, 2,886 people aged 30 and older are being recruited at 18 NHS sites across the UK for the trial, with the first booster jabs administered in early June.
Joseph Gamp
PRINCE WILLIAM, 38, SHOWS OFF GUNS AS HE GETS VACCINE AFTER HAVING COVID LAST YEAR AS JABS OFFERED TO OVER-34S
Prince William, 38, shows off guns as he gets vaccine after having Covid last year as jabs offered to over-34s
Joseph Gamp
JAPAN APPROVES MODERNA AND ASTRAZENECA VACCINES
Japanese regulators recommended the approval of Covid-19 vaccines developed by Moderna Inc and AstraZeneca PLC on Thursday, paving the way for the country to speed up its slow-moving vaccination campaign.
The recommendations by a health ministry panel precede official approval by the government as early as Friday, health minister Norihisa Tamura said on Thursday.
Coronavirus UK news - Third Covid wave fears as Indian variant cases rise and home quarantines not working the-sun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from the-sun.com Daily Mail and Mail on Sunday newspapers.
The new vaccine is the first of its kind Up to 200 volunteers are being recruited for a new Covid-19 vaccine which is the first of its kind. It is the only inactive drug under clinical development in Europe which uses pathogen that has been modified so that it cannot replicate to stimulate our immune system. It has also been adjuvanted, which means it contains substances that increase its potency to create a stronger immune response. Inactivated vaccines are a well-established technology used over the last 100 years to vaccinate billions for seasonal flu, hepatitis A, polio and rabies. Following positive safety and immunogenicity study results from the Phase 1/2 stage, which showed the study vaccine dose was “well tolerated with no safety concerns identified”, recruitment to the final Phase 2/3 stage of the study will begin in the final week of April.
Patients are needed for a new Covid trial HEALTH chiefs have issued an appeal for people in Dumbarton and the Vale who have recently been diagnosed with Covid-19 to take part in a treatment trial. Researchers from NHS Greater Glasgow and Clyde are recruiting members of the public to help evaluate the effectiveness of antiviral tablet favipiravir in managing the disease. The medication targets the early stages of infection and must be taken within four days of a positive result. It is intended for people with milder symptoms who can safely take part from home. Half the patients involved will receive the drug twice a day for ten days alongside standard treatment, with the other half receiving standard treatment for comparison.